Literature DB >> 23239114

Sphingolipid content in the human uterus and pair-matched uterine leiomyomas remains constant.

Knapp Paweł1, Adrian Chabowski, Jan Górski.   

Abstract

In the present work we sought to investigate the content of sphingolipids (sphingosine, sphinganine, sphingosine-1-phosphate and ceramide) in human fibroids and pair-matched healthy uterus tissue. We demonstrated that, in uterine leiomyomas, the contents of sphingosine, sphinganine, sphingosine-1-phosphate and ceramide remains quite constant. However, a trend towards elevation of ceramide and simultaneous reduction of sphingosine-1 phosphate levels was also noticed. Additionally, in uterine leiomyomas we found relevant activation of both PTEN and MAPK(ERK1/2) signaling pathways with only a minor change in AKT activity and relatively absent HIF-1α/AMPK activation. In conclusion, rather modest changes in sphingolipids are correlated with the activation of PTEN and MAPK(ERK1/2) signaling proteins in human uterine leiomyomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23239114     DOI: 10.1007/s11745-012-3746-2

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  26 in total

1.  Antitumor activity of sphingosine kinase inhibitors.

Authors:  Kevin J French; John J Upson; Staci N Keller; Yan Zhuang; Jong K Yun; Charles D Smith
Journal:  J Pharmacol Exp Ther       Date:  2006-04-21       Impact factor: 4.030

Review 2.  Dysregulation of sphingolipid metabolism in cancer.

Authors:  Lindsay K Ryland; Todd E Fox; Xin Liu; Thomas P Loughran; Mark Kester
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

3.  Altered sphingolipid metabolism in human endometrial cancer.

Authors:  Paweł Knapp; Marcin Baranowski; Małgorzata Knapp; Piotr Zabielski; Agnieszka U Błachnio-Zabielska; Jan Górski
Journal:  Prostaglandins Other Lipid Mediat       Date:  2010-03-10       Impact factor: 3.072

4.  Roles of sphingosine 1-phosphate on tumorigenesis.

Authors:  Yuan-Li Huang; Wei-Pang Huang; Hsinyu Lee
Journal:  World J Biol Chem       Date:  2011-02-26

5.  Ceramide synthase-dependent ceramide generation and programmed cell death: involvement of salvage pathway in regulating postmitochondrial events.

Authors:  Thomas D Mullen; Russell W Jenkins; Christopher J Clarke; Jacek Bielawski; Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

6.  Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.

Authors:  C D Swartz; C A Afshari; L Yu; K E Hall; D Dixon
Journal:  Mol Hum Reprod       Date:  2005-05-06       Impact factor: 4.025

Review 7.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

8.  Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma.

Authors:  Nasser Chegini; Lori Kornberg
Journal:  J Soc Gynecol Investig       Date:  2003-01

9.  Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas.

Authors:  Lan Peng; Yong Wen; Yulong Han; Anran Wei; Guizhi Shi; Masashi Mizuguchi; Peng Lee; Eva Hernando; Khush Mittal; Jian-Jun Wei
Journal:  Fertil Steril       Date:  2008-04-25       Impact factor: 7.329

Review 10.  AMPK in Health and Disease.

Authors:  Gregory R Steinberg; Bruce E Kemp
Journal:  Physiol Rev       Date:  2009-07       Impact factor: 37.312

View more
  1 in total

1.  PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes PTEN & LKB1 in human uterine leiomyomas.

Authors:  Annu Makker; Madhu Mati Goel; Abbas Ali Mahdi; Vikram Bhatia; Vinita Das; Anjoo Agarwal; Amita Pandey
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.